Biotech Values

[DewDiligence]

AGN, ACT close to consummating friendly merger, according to WSJ:

http://online.wsj.com/articles/allergan-actavis-near-deal-1416162347

Actavis PLC and Allergan Inc. are nearing a friendly deal that could swipe the Botox maker from hostile suitor Valeant Pharmaceuticals International Inc., according to people familiar with the matter.

The boards of the two companies are expected to meet to review a cash-and-stock deal, the people said. An agreement could be announced as early as Monday…

…An agreement could thwart Allergan’s months of efforts to fend off Valeant and activist investor William Ackman, who teamed in a takeover effort.

Clearly, the word, thwart is not what was intended in this context!